10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609

RIPK3 Antibody (N-term) Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP7184a

Specification

RIPK3 Antibody (N-term) - Product Information

Application WB, IHC-P,E Primary Accession Q9Y572 Reactivity Human Host Rabbit Clonality Polyclonal Isotype Rabbit Ig Antigen Region 1-30

RIPK3 Antibody (N-term) - Additional Information

Gene ID 11035

Other Names Western blot analysis of RIP3 (RIPK3) Receptor-interacting Antibody (N-term) (Cat.# AP7184a) in Ramos serine/threonine-protein kinase 3, RIP-like cell line lysates (35ug/lane). RIPK3 (arrow) protein kinase 3, Receptor-interacting was detected using the purified Pab. protein 3, RIP-3, RIPK3, RIP3

Target/Specificity This RIPK3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human RIPK3.

Dilution WB~~1:1000 IHC-P~~1:10~50

Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Formalin-fixed and paraffin-embedded Ammonium Sulfate (SAS) precipitation human lung carcinoma tissue reacted with followed by dialysis against PBS. RIP3 (RIPK3) antibody (N-term) (Cat.# AP7184a), which was peroxidase-conjugated Storage to the secondary antibody, followed by DAB Maintain refrigerated at 2-8°C for up to 2 staining. This data demonstrates the use of weeks. For long term storage store at -20°C this antibody for immunohistochemistry; in small aliquots to prevent freeze-thaw clinical relevance has not been evaluated. cycles.

Precautions RIPK3 Antibody (N-term) - Background RIPK3 Antibody (N-term) is for research use only and not for use in diagnostic or The product of this is a member of the therapeutic procedures. receptor-interacting protein (RIP) family of

Page 1/4 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609

serine/threonine protein kinases, and contains RIPK3 Antibody (N-term) - Protein Information a C-terminal domain unique from other RIP family members. The encoded protein is predominantly localized to the cytoplasm, and Name RIPK3 (HGNC:10021) can undergo nucleocytoplasmic shuttling dependent on novel nuclear localization and Function export signals. It is a component of the tumor Serine/threonine-protein kinase that necrosis factor (TNF) receptor-I signaling activates necroptosis and apoptosis, two parallel forms of cell death (PubMed:19524512, PubMed:19524513, Yu P.W., Huang B.C.B., Shen M., Quast J., Chan PubMed:22265413, Baldwin D.T., Stewart T.A., Dixit V.M.; J. Biol. PubMed:22265414, PubMed:22421439, PubMed:29883609). Necroptosis, a programmed cell death process in response to death-inducing TNF-alpha family members, is triggered by RIPK3 following activation by ZBP1 (PubMed:19524512, PubMed:19524513, PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:29883609, PubMed:32298652). Activated RIPK3 forms a necrosis-inducing complex and mediates phosphorylation of MLKL, promoting MLKL localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane

Page 2/4 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609

damage (PubMed:19524512, PubMed:19524513, PubMed:22265413, PubMed:22265414, PubMed:22421439, PubMed:25316792, PubMed:29883609). In addition to TNF-induced necroptosis, necroptosis can also take place in the nucleus in response to orthomyxoviruses infection: following ZBP1 activation, which senses double-stranded Z-RNA structures, nuclear RIPK3 catalyzes phosphorylation and activation of MLKL, promoting disruption of the nuclear envelope and leakage of cellular DNA into the cytosol (By similarity). Also regulates apoptosis: apoptosis depends on RIPK1, FADD and CASP8, and is independent of MLKL and RIPK3 kinase activity (By similarity). Phosphorylates RIPK1: RIPK1 and RIPK3 undergo reciprocal auto- and trans-phosphorylation (PubMed:19524513). In some cell types, also able to restrict viral replication by promoting cell death- independent responses (By similarity). In response to Zika virus infection in neurons, promotes a cell death-independent pathway that restricts viral replication: together with ZBP1, promotes a death- independent transcriptional program that modifies the cellular metabolism via up-regulation expression of the enzyme ACOD1/IRG1 and production of the metabolite itaconate (By similarity). Itaconate inhibits the activity of succinate dehydrogenase, generating a metabolic state in neurons that suppresses replication of viral genomes (By similarity). RIPK3 binds to and enhances the activity of three metabolic enzymes: GLUL, GLUD1, and PYGL (PubMed:19498109). These metabolic enzymes may eventually stimulate the tricarboxylic acid cycle and oxidative phosphorylation, which could result in enhanced ROS production (PubMed:19498109).

Cellular Location Cytoplasm, cytosol. Nucleus {ECO:0000250|UniProtKB:Q9QZL0}. Note=Mainly cytoplasmic Present in the nucleus in response to influenza A virus (IAV) infection. {ECO:0000250|UniProtKB:Q9QZL0}

Tissue Location Highly expressed in the pancreas. Detected at lower levels in heart, placenta, lung and kidney

RIPK3 Antibody (N-term) - Protocols

Provided below are standard protocols that you may find useful for product applications.

• Western Blot • Blocking Peptides • Dot Blot • Immunohistochemistry • Immunofluorescence • Immunoprecipitation • Flow Cytomety • Cell Culture RIPK3 Antibody (N-term) - Citations Cell Death Pathways in Mutant Rhodopsin Rat Models Identifies Genotype-Specific Targets Controlling Retinal Degeneration. NLRP3 inflammasome activation drives bystander cone photoreceptor cell death in a P23H rhodopsin model of retinal degeneration. Pax2 regulates a -dependent molecular switch that drives tissue fusion during eye development.

Page 4/4

Powered by TCPDF (www.tcpdf.org)